Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of QAW039 when added to current therapy in
patients that have sputum eosinophilia and persistent asthma.